Prevalence and characteristics of gonadoblastoma in a retrospective multi-center study with follow-up investigations of 70 patients with Turner syndrome and a 45,X/46,XY karyotype

in European Journal of Endocrinology
Authors:
Daphné Karila Sorbonne University, Endocrine Unit, Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN (id 739527), Saint-Antoine Hospital, AP-HP, Paris, France

Search for other papers by Daphné Karila in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-2235-629X
,
Bruno Donadille Sorbonne University, Endocrine Unit, Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN (id 739527), Saint-Antoine Hospital, AP-HP, Paris, France

Search for other papers by Bruno Donadille in
Current site
Google Scholar
PubMed
Close
,
Juliane Léger Pediatric Endocrinology and Diabetology, Robert-Debré Hospital, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN Paris, France

Search for other papers by Juliane Léger in
Current site
Google Scholar
PubMed
Close
,
Claire Bouvattier Pediatric Endocrinology and Diabetology, Bicêtre Hospital, Centre de référence des maladies rares du développement (DEVGEN), Endo-ERN Le Kremlin Bicêtre, France

Search for other papers by Claire Bouvattier in
Current site
Google Scholar
PubMed
Close
,
Anne Bachelot Sorbonne University, Department of Endocrinology and Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, CRMERC, Endo-ERN, Pitié-Salpêtrière Hospital, AP-HP, Paris, France

Search for other papers by Anne Bachelot in
Current site
Google Scholar
PubMed
Close
,
Veronique Kerlan Endocrine Unit, CHU Brest, France

Search for other papers by Veronique Kerlan in
Current site
Google Scholar
PubMed
Close
,
Sophie Catteau-Jonard University Lille, Gynecology, CHU Lille, Lille, France

Search for other papers by Sophie Catteau-Jonard in
Current site
Google Scholar
PubMed
Close
,
Sylvie Salenave Endocrinology and metabolism, Bicêtre Hospital, Le Kremlin Bicetre, APHP, France

Search for other papers by Sylvie Salenave in
Current site
Google Scholar
PubMed
Close
,
Frédérique Albarel Department of Endocrinology, Assistance Publique-Hôpitaux de Marseille (AP-HM), Hôpital de la Conception, Centre de référence des Maladies Rares de l’hypophyse HYPO, 13005 Marseille, FRANCE

Search for other papers by Frédérique Albarel in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-6995-2590
,
Claire Briet Endocrinology, Diabetology, and Nutrition, Centre de référence des maladies rares de la Thyroïde et des Récepteurs Hormonaux, ENDO ERN CHU Angers, Angers, France

Search for other papers by Claire Briet in
Current site
Google Scholar
PubMed
Close
,
Regis Coutant Pediatric Endocrinology and Diabetology, Centre de référence des maladies rares de la Thyroïde et des Récepteurs Hormonaux Endo-ERN CHU Angers, Angers, France

Search for other papers by Regis Coutant in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-6332-4243
,
Aude Brac De La Perriere Endocrinology and Diabetology and metabolic diseases, Hôpital Louis Pradel, Bron, France

Search for other papers by Aude Brac De La Perriere in
Current site
Google Scholar
PubMed
Close
,
Alexander Valent Department of Molecular Pathology, Cytogenetics and Medical Biology, Institut Gustave Roussy, Villejuif, France

Search for other papers by Alexander Valent in
Current site
Google Scholar
PubMed
Close
,
Jean-Pierre Siffroi Sorbonne University, Genetic unit, Trousseau Hospital, Paris, APHP, France
INSERM UMR-833, Trousseau Hospital, Paris, France

Search for other papers by Jean-Pierre Siffroi in
Current site
Google Scholar
PubMed
Close
, and
Sophie Christin-Maitre Sorbonne University, Endocrine Unit, Reproductive Medicine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement (CRMERC), Endo-ERN (id 739527), Saint-Antoine Hospital, AP-HP, Paris, France
INSERM UMR-833, Trousseau Hospital, Paris, France

Search for other papers by Sophie Christin-Maitre in
Current site
Google Scholar
PubMed
Close

Correspondence should be addressed to D Karila; Email: daphne.karila@aphp.fr
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

Introduction

A gonadectomy is currently recommended in patients with Turner syndrome (TS) and a 45,X/46,XY karyotype, due to a potential risk of gonadoblastoma (GB). However, the quality of evidence behind this recommendation is low.

Objective

This study aimed to evaluate the prevalence of GB, its characteristics, as well as its risk factors, according to the type of Y chromosomal material in the karyotype.

Methods

Our study within French rare disease centers included patients with TS and a 45,X/46,XY karyotype, without ambiguity of external genitalia. Clinical characteristics of the patients, their age at gonadectomy, and gonadal histology were recorded. The regions of the Y chromosome, the presence of TSPY regions, and the percentage of 45,X/46,XY mosaicism were evaluated.

Results

A total of 70 patients were recruited, with a median age of 29.5 years (21.0–36.0) at the end of follow-up. Fifty-eight patients had a gonadectomy, at a mean age of 15 ± 8 years. GB was present in nine cases. Two were malignant, which were discovered at the age of 14 and 32 years, without metastases. Neither the percentage of XY cells within the 45,X/46,XY mosaicism nor the number of TSPY copies was statistically different in patients with or without GB (P = 0.37). However, the entire Y chromosome was frequent in patients with GB (6/9).

Conclusions

In our study, including a large number of patients with 45,X/46,XY TS, the prevalence of gonadoblastoma is 12.8%. An entire Y chromosome appears as the main risk factor of GB and should favor early gonadectomy.

Significant statement

About 10% of patients with TS have a karyotype containing Y chromosomal material: 45,X/46,XY. Its presence is related to the risk of GB. Therefore, a prophylactic gonadectomy is currently recommended in such patients. However, the quality of evidence is low. Our objective was to evaluate the prevalence of GB according to the type of Y-chromosomal material. We found a prevalence of GB of 12.8% in a cohort of 70 TS patients. No sign of hyperandrogenism was observed. The entire Y chromosome was the most frequent type of Y-material in patients with GB. As the prognosis of these tumors was good, a delay of surgery might be discussed.

 

  • Collapse
  • Expand

     European Society of Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 2204 54 40
Full Text Views 87 0 0
PDF Downloads 138 0 0
  • 1

    Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA & Rubin K et al.Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. European Journal of Endocrinology 2017 177 G1G70. (https://doi.org/10.1530/EJE-17-0430)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Cameron-Pimblett A, La Rosa C, King TFJ, Davies MC, Conway GS. The Turner syndrome life course project: karyotype-phenotype analyses across the lifespan. Clinical Endocrinology 2017 87 532538. (https://doi.org/10.1111/cen.13394)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3

    de Marqui AB, da Silva-Grecco RL, Balarin MA. Prevalence of Y-chromosome sequences and gonadoblastoma in Turner syndrome. Revista Paulista de Pediatria : Orgao Oficial da Sociedade de Pediatria de Sao Paulo 2016 34 114121. (https://doi.org/10.1016/j.rpped.2015.06.007)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Berta P, Hawkins JR, Sinclair AH, Taylor A, Griffiths BL, Goodfellow PN, Fellous M. Genetic evidence equating SRY and the testis-determining factor. Nature 1990 348 448450. (https://doi.org/10.1038/348448A0)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Martinerie L, Morel Y, Gay C-L, Pienkowski C, de Kerdanet M, Cabrol S, Lecointre C, Coutant R, Baron S & Colle M et al.Impaired puberty, fertility, and final stature in 45,X/46,XY mixed gonadal dysgenetic patients raised as boys. European Journal of Endocrinology 2012 166 687694. (https://doi.org/10.1530/EJE-11-0756)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    Dumeige L, Chatelais L, Bouvattier C, De Kerdanet M, Hyon C, Esteva B, Samara-Boustani D, Zenaty D, Nicolino M & Baron S et al.Should 45,X/46,XY boys with no or mild anomaly of external genitalia be investigated and followed up? European Journal of Endocrinology 2018 179 181190. (https://doi.org/10.1530/EJE-18-0309)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Scully RE Gonadoblastoma: a gonadal tumor related to the dysgerminoma (seminoma) and capable of sex-hormone production. Cancer. Boston: Massachusetts General Hospital, 1953 3 9.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Roth LM, Cheng L. Gonadoblastoma: origin and outcome. Human Pathology 2020 100 4753. (https://doi.org/10.1016/j.humpath.2019.11.005)

  • 9

    Lau YFC, Li Y, Kido T, Lau Y-FC, Li Y, Kido T. Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Research. (Part C), Embryo Today: Reviews 2009 87 114122. (https://doi.org/10.1002/bdrc.20144)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Hertel JD, Huettner PC, Dehner LP, Pfeifer JD. The chromosome Y-linked testis-specific protein locus TSPY1 is characteristically present in gonadoblastoma. Human Pathology 2010 41 15441549. (https://doi.org/10.1016/j.humpath.2010.04.007)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Schnieders F, Dörk T, Arnemann J, Vogel T, Werner M, Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Human Molecular Genetics 1996 5 18011807. (https://doi.org/10.1093/hmg/5.11.1801)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Silveri M, Grossi A, Bassani F, Orazi C, Camassei F, Zaccara A, Silveri M, Grossi A, Bassani F, Cinzia Orazi FD. Ullrich–Turner syndrome and tumor risk: is there another chance to early gonadectomy in positive TSPY and SRY patients? European Journal of Pediatric Surgery 2015 26 273276. (https://doi.org/10.1055/s-0035-1551568)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Dejonckheere C, Moyson C, de Zegher F, Antonio L, Van Buggenhout G, Decallonne B. Neoplasia in Turner syndrome: a retrospective cohort study in a tertiary referral centre in Belgium. Acta Clinica Belgica 2022 77 8692. (https://doi.org/10.1080/17843286.2020.1805237)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Zelaya G, López Marti JM, Marino R, Garcia de Dávila MT, Gallego MS. Gonadoblastoma in patients with Ullrich-Turner syndrome. Pediatric and Developmental Pathology 2015 18 117121. (https://doi.org/10.2350/14-08-1539-OA.1)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Dabrowski E, Johnson EK, Patel V, Hsu Y, Davis S, Goetsch AL, Habiby R, Brickman WJ, Finlayson C. Turner syndrome with Y chromosome: spontaneous Thelarche, Menarche and Risk of Malignancy. Journal of Pediatric and Adolescent Gynecology 2019. (https://doi.org/10.1016/j.jpag.2019.08.011)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Cools M, Pleskacova J, Stoop H, Hoebeke P, Van Laecke E, Drop SLS, Lebl J, Oosterhuis JW, Looijenga LHJ & Wolffenbuttel KP et al.Gonadal pathology and tumor risk in relation to clinical characteristics in patients with 45,X/46,XY mosaicism. Journal of Clinical Endocrinology and Metabolism 2011 96 E1171E1180. (https://doi.org/10.1210/jc.2011-0232)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Poyrazoglu S, Bas F, Karaman B, Yildiz M, Basaran S, Darendeliler F. Growth and relationship of phenotypic characteristics with gonadal pathology and tumour risk in patients with 45, X/46, XY mosaicism/46. Clinical Endocrinology 2021 94 973979. (https://doi.org/10.1111/cen.14437)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Coyle D, Kutasy B, Suyin KH, Antao B, Lynch SA, McDermott MB, O’Connell SM, Quinn F. Gonadoblastoma in patients with 45,X/46,XY mosaicism: A 16-year experience. Journal of Pediatric Urology 2016 12 283.e1283.e7. (https://doi.org/10.1016/j.jpurol.2016.02.009)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Cortés-Gutiérrez EI, Herrera-Bartolo R, Davila-Rodriguez MI, Palacios-Saucedo GC, Vargas-Villarreal J, Romero-Villarreal JB. Molecular detection of cryptic Y-chromosomal material in patients with Turner syndrome. Oncology Reports 2012 28 12051210. (https://doi.org/10.3892/or.2012.1916)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Knauer-Fischer S, Besikoglu B, Inta I, Kneppo C, Vogt PH, Bettendorf M. Analyses of gonadoblastoma Y (GBY)-locus and of Y centromere in Turner syndrome patients. Experimental and Clinical Endocrinology and Diabetes 2015 123 6165. (https://doi.org/10.1055/s-0034-1387734)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Freriks K, Timmers HJ, Netea-Maier RT, Beerendonk CC, Otten BJ, van Alfen-van der Velden JA, Traas MA, Mieloo H, van de Zande GW & Hoefsloot LH et al.Buccal cell FISH and blood PCR-Y detect high rates of X chromosomal mosaicism and Y chromosomal derivatives in patients with Turner syndrome. European Journal of Medical Genetics 2013 56 497501. (https://doi.org/10.1016/j.ejmg.2013.07.008)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Palma I, Garibay N, Pena-Yolanda R, Contrerase A, Raya A, Dominguez C, Romero M, Aristi G, Queipo G. Utility of OCT3/4, TSPY and β-catenin as biological markers for gonadoblastoma formation and malignant germ cell tumor development in dysgenetic gonads. Disease Markers 2013 34 419424. (https://doi.org/10.3233/DMA-130972)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. Journal of Pathology 2007 211 19. (https://doi.org/10.1002/path.2105)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Vogt PH, Zimmer J, Bender U, Strowitzki T. AZFa candidate gene UTY and its X homologue UTX are expressed in human germ cells. Reproduction and Fertility 2021 2 151160. (https://doi.org/10.1530/RAF-20-0049)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Vogt PH, Besikoglu B, Bettendorf M, Frank-Herrmann P, Zimmer J, Bender U, Knauer-Fischer S, Choukair D, Sinn P & Doerr HG et al.Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks§. Systems Biology in Reproductive Medicine 2022 68 247257. (https://doi.org/10.1080/19396368.2022.2057258)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Bianco B, Vannucci Nunes Lipay MV, Melaragno MI, Guedes AD, Verreschi ITN. Detection of hidden Y mosaicism in Turner’s syndrome: importance in the prevention of gonadoblastoma. Journal of Pediatric Endocrinology and Metabolism 2006 19 11131117. (https://doi.org/10.1515/jpem.2006.19.9.1113)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Graff A, Donadille B, Morel H, Villy MC, Bourcigaux N, Vatier C, Borgel A, Khodawardi A, Siffroi JP, Christin-Maitre S. Added value of buccal cell FISH analysis in the diagnosis and management of Turner syndrome. Human Reproduction 2020 35 23912398. (https://doi.org/10.1093/humrep/deaa197)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Kwon A, Hyun SE, Jung MK, Chae HW, Lee WJ, Kim TH, Kim DH & & Kim H-S. Risk of Gonadoblastoma Development in Patients with Turner Syndrome with Cryptic Y Chromosome Material. Hormones and Cancer 2017 8 166173. (https://doi.org/10.1007/s12672-017-0291-8)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Rojek A, Obara-Moszynska M, Kolesinska Z, Rabska-Pietrzak B & & Niedziela M. Molecular Detection and Incidence of Y Chromosomal Material in Patients with Turner Syndrome. Sexual Development 2017 11 254261. (https://doi.org/10.1159/000484880)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Barros B A, Moraes S G, Coeli F B, Assumpção J G, De Mello M P, Maciel-Guerra A T, Carvalho A B, Viguetti-Campos N, Vieira T A P, Amstalden E M Iet al. OCT4 immunohistochemistry may be necessary to identify the real risk of gonadal tumors in patients with Turner syndrome and Y chromosome sequences. Human Reproduction 2011 26 34503455. (https://doi.org/10.1093/humrep/der310)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Sallai Á, Sólyom J, Dobos M, Szabó J, Halász Z, Ságodi L, Niederland T, Kozári A, Bertalan R, Ugocsai P & & Fekete G. Y- chromosome markers in Turner syndrome : Screening of 130 patients. Journal of Endocrinological Investigation 2010 33 222227. (https://doi.org/10.3275/6442)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Bianco B, Lipay M, Guedes A, Oliveira K & Verreschi IT. SRY gene increases the risk of developing gonadoblastoma and/or nontumoral gonadal lesions in Turner syndrome. International Journal of Gynecological Patholology 2009 28 197202. (https://doi.org/10.1097/PGP.0b013e318186a825)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Brant W O, Rajimwale A, Lovell M A, Travers S H, Furness P D, Sorensen III, Oottamasathien M, S & & Koyle M A. Gonadoblastoma and Turner Syndrome. The Journal of Urology 2006 175 18581860. (https://doi.org/10.1016/S0022-5347(05)00932-8)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Mazzanti L, Cicognani A, Baldazzi L, Bergamaschi R, Scarano E, Strocchi S, Nicoletti A, Mencarelli F, Pittalis M, Forabosco Aet al. Gonadoblastoma in and Y-chromosome-derived material. American Journal of Medical Genetics 2005 135 150154. (https://doi.org/10.1002/ajmg.a.30569)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Álvarez-Nava F, Soto M, Sanchez M A, Fernàndez E & & Lanes R. Molecular analysis in Turner Syndrome. The Journal of Pediatrics 2003 142 336340. (https://doi.org/10.1067/mpd.2003.95)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Mancilla EE, Poggi H, Repetto G, Rumie H, Garcıa H, Ugarte F, Hidalgo S, Jara A, Muzzo S, Panteon Eet al. Y chromosome sequences in Turner’s syndrome: association with virilization and gonadoblastoma. Journal of Pediatric Endocrinology and Metabolism 2003 16 11571163. (https://doi.org/10.1515/jpem.2003.16.8.1157)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Gravholt CH, Fedder J, Naeraa RW & & Muller J. Occurrence of Gonadoblastoma in Females with Turner Syndrome and Y Chromosome Material: A Population Study. The Journal of Clinical Endocrinology & Metabolism 2000 85 31993202. (https://doi.org/10.1210/jcem.85.9.6800)

    • PubMed
    • Search Google Scholar
    • Export Citation